serw-MX  [xml]  

 DeCS Categories

A02 Musculoskeletal System .
A02.633 Muscles .
A02.633.580 Myocardium .
A07 Cardiovascular System .
A07.541 Heart .
A07.541.704 Myocardium .
A10 Tissues .
A10.690 Muscles .
A10.690.552 Muscle, Striated .
A10.690.552.750 Myocardium .
C14 Cardiovascular Diseases .
C14.280 Heart Diseases .
C14.280.238 Cardiomyopathies .
C14.280.238.625 Myocarditis .
C14.280.671 Myocardial Stunning .
C23 Pathological Conditions, Signs and Symptoms .
C23.888 Signs and Symptoms .
C23.888.582 Myocardial Stunning .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.954 Therapeutic Uses .
D27.505.954.411 Cardiovascular Agents .
D27.505.954.411.222 Cardiotonic Agents .
D27.720 Specialty Uses of Chemicals .
D27.720.799 Protective Agents .
D27.720.799.080 Cardiotonic Agents .
 Synonyms & Historicals
Myocardial Stunning .
Myocardium, Stunned .
Stunning, Myocardial .
Stunned Myocardium .
Hibernation, Myocardial .
Myocardial Hibernation .
Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. .
Myocardium .
Cardiac Muscle .
Myocardia .
Cardiac Muscles .
Heart Muscle .
Heart Muscles .
Muscles, Cardiac .
Muscles, Heart .
Muscle, Cardiac .
Muscle, Heart .
The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. .
Myocarditis .
Myocarditides .
Carditis .
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. .
Cardiomyopathies .
Cardiomyopathies, Primary .
Cardiomyopathies, Secondary .
Primary Myocardial Diseases .
Secondary Myocardial Diseases .
Cardiomyopathy .
Cardiomyopathy, Primary .
Cardiomyopathy, Secondary .
Disease, Myocardial .
Disease, Primary Myocardial .
Disease, Secondary Myocardial .
Diseases, Myocardial .
Diseases, Primary Myocardial .
Diseases, Secondary Myocardial .
Myocardial Disease .
Myocardial Disease, Primary .
Myocardial Disease, Secondary .
Myocardiopathy .
Primary Cardiomyopathies .
Primary Cardiomyopathy .
Primary Myocardial Disease .
Secondary Cardiomyopathies .
Secondary Cardiomyopathy .
Secondary Myocardial Disease .
Myocardial Diseases .
Myocardial Diseases, Primary .
Myocardial Diseases, Secondary .
Myocardiopathies .
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). .
Cardiotonic Agents .
Cardiotonic Drugs .
Cardiotonics .
Cardioprotective Agents .
Cardiac Stimulants .
Inotropic Agents, Positive Cardiac .
Myocardial Stimulants .
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). .